ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Allogene Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Allogene Therapeutics, INC. (Allogene Therapeutics, INC. 401(k) Plan · EIN 82-3562771 · PN 001): $44.03M net assets, 233 active participants, and $9.06 per $10,000 (9.06 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAllogene Therapeutics, INC.
Filing IdentifierAllogene Therapeutics, INC. 401(k) Plan · EIN 82-3562771 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$44.03M
Active Participants233
Direct Admin Fee Rate$9.06 per $10,000 (9.06 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI